Utilization of oxidation reactions for the spectrophotometric determination of captopril using brominating agents.
Three simple, accurate and sensitive methods (A-C) for the spectrophotometric assay of captopril (CPL) in bulk drug, in dosage forms and in the presence of its oxidative degradates have been described. The methods are based on the bromination of captopril with a solution of excess brominating mixture in hydrochloric acid medium. After bromination, the excess brominating mixture is followed by the estimation of surplus bromine by three different reaction schemes. In the first method (A), the determination of the residual bromine is based on its ability to bleach the indigo carmine dye and measuring the absorbance at 610 nm. Method B, involves treating the unreacted bromine with a measured excess of iron(II) and the remaining iron(II) is complexed with 1,10-phenanthroline and the increase in absorbance is measured at 510 nm. In method (C), the surplus bromine is treated with excess of iron(II) and the resulting iron(III) is complexed with thiocyanate and the absorbance is measured at 478 nm. In all the methods, the amount of bromine reacted corresponds to the drug content. The different experimental parameters affecting the development and stability of the color are carefully studied and optimized. Beer's law is valid within a concentration range of 0.4-6.0, 0.4-2.8 and 1.2-4.8 microg mL(-1) for methods A, B and C, respectively. The calculated apparent molar absorptivity was found to be 5.16x10(4), 9.95x10(4) and 1.74x10(5)L mol(-1) cm(-1), for methods A, B and C, respectively. Sandell's sensitivity, correlation coefficients, detection and quantification limits are also reported. No interference was observed from common additives found in pharmaceutical preparations. The proposed methods are successfully applied to the determination of CPL in the tablet formulations with mean recoveries of 99.94-100.11% and the results were statistically compared with those of a reference method by applying Student's t- and F-test.
El-Didamony
Akram M
AM
Chemistry Department, Faculty of Science, Zagazig University, Zagazig, Egypt. ak eldidamony@yahoo.com
Erfan
Eman A H
EA
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000032:analysis*; D000959:Antihypertensive Agents / Q000032:analysis*; D001966:Bromine / Q000737:chemistry*; D002216:Captopril / Q000032:analysis*; D002614:Chelating Agents / Q000737:chemistry; D004396:Coloring Agents / Q000737:chemistry; D054879:Halogenation; D007203:Indigo Carmine / Q000737:chemistry; D015394:Molecular Structure; D010084:Oxidation-Reduction; D004364:Pharmaceutical Preparations / Q000032:analysis; D010618:Phenanthrolines / Q000737:chemistry; D013053:Spectrophotometry / Q000379:methods*; D013861:Thiocyanates / Q000737:chemistry
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002614:Chelating Agents; D004396:Coloring Agents; D004364:Pharmaceutical Preparations; D010618:Phenanthrolines; D013861:Thiocyanates; D002216:Captopril; D007203:Indigo Carmine; C031760:thiocyanate; D001966:Bromine; C025205:1,10-phenanthroline